Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Feb;63(2):187–190. doi: 10.1038/bjc.1991.46

The killing effect of 4-S-cysteaminylphenol, a newly synthesised melanin precursor, on B16 melanoma cell lines.

I Yamada 1, S Seki 1, S Ito 1, S Suzuki 1, O Matsubara 1, T Kasuga 1
PMCID: PMC1971795  PMID: 1997095

Abstract

We have examined the killing effect of 4-S-cysteaminylphenol (4-S-CAP), a newly synthesised melanin precursor, on B16 melanoma cell lines possessing different melanin-producing activities and found it to be particularly effective in heavily melanised melanoma cells, but less so in moderately melanised melanoma cells, and having no effect on amelanotic melanoma cells and nonmelanoma cells. Thus, it was found that the killing effect of 4-S-CAP is highly dependent upon the synthesis of melanin and tyrosinase in melanoma cells, suggesting that 4-S-CAP may become toxic to melanoma cells only after oxidation by tyrosinase. The killing activity of 4-S-CAP also was found to be associated with a profound inhibition of the thymidine incorporation in pigmented melanoma cells, as compared to the uridine and leucine incorporation. Further, the inhibition of DNA synthesis was most pronounced in heavily melanised melanoma cells, less so in moderately melanised melanoma cells, and not seen in amelanotic melanoma cells. As a possible mechanism that might account for this action, it may be that 4-S-CAP is oxidised by tyrosinase to the o-quinone form via the catechol derivative and that some of the quinones then conjugate with sulfhydryl enzymes including DNA polymerase, thus exerting a killing activity for pigmented melanoma cells. Thus, 4-S-CAP appears to provide a new, effective cytotoxic agent for rational chemotherapy of malignant melanomas.

Full text

PDF
187

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dean P. N. A simplified method of DNA distribution analysis. Cell Tissue Kinet. 1980 May;13(3):299–308. doi: 10.1111/j.1365-2184.1980.tb00468.x. [DOI] [PubMed] [Google Scholar]
  2. Graham D. G., Tiffany S. M., Bell W. R., Jr, Gutknecht W. F. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol. 1978 Jul;14(4):644–653. [PubMed] [Google Scholar]
  3. Graham D. G., Tiffany S. M., Vogel F. S. The toxicity of melanin precursors. J Invest Dermatol. 1978 Feb;70(2):113–116. doi: 10.1111/1523-1747.ep12541249. [DOI] [PubMed] [Google Scholar]
  4. Ito S., Kato T., Ishikawa K., Kasuga T., Jimbow K. Mechanism of selective toxicity of 4-S-cysteinylphenol and 4-S-cysteaminylphenol to melanocytes. Biochem Pharmacol. 1987 Jun 15;36(12):2007–2011. doi: 10.1016/0006-2952(87)90501-6. [DOI] [PubMed] [Google Scholar]
  5. Miura S., Ueda T., Jimbow K., Ito S., Fujita K. Synthesis of cysteinylphenol, cysteaminylphenol, and related compounds, and in vivo evaluation of antimelanoma effect. Arch Dermatol Res. 1987;279(4):219–225. doi: 10.1007/BF00417318. [DOI] [PubMed] [Google Scholar]
  6. Oikawa A., Saeki H., Akiyama T., Matsumoto J. Electron microscopic evidence for stimulation of melanosomal maturation by lysosomotropic agents and monensin in cultured B16 mouse melanoma cells. Pigment Cell Res. 1987;1(1):44–50. doi: 10.1111/j.1600-0749.1987.tb00533.x. [DOI] [PubMed] [Google Scholar]
  7. Pawelek J. M. Factors regulating growth and pigmentation of melanoma cells. J Invest Dermatol. 1976 Apr;66(4):201–209. doi: 10.1111/1523-1747.ep12482134. [DOI] [PubMed] [Google Scholar]
  8. Pawelek J., Wong G., Sansone M., Morowitz J. Molecular biology of pigment cells. Molecular controls in mammalian pigmentation. Yale J Biol Med. 1973 Dec;46(5):430–443. [PMC free article] [PubMed] [Google Scholar]
  9. Rsoswsky A., Wick M. M., Kim S. H. Structural analogues of L-glutamic Acid gamma-(4-hydroxyanilide) and gamma-(3,4-dihydroxyanilde) as potential agents against melanoma. J Med Chem. 1979 Sep;22(9):1034–1037. doi: 10.1021/jm00195a004. [DOI] [PubMed] [Google Scholar]
  10. Siegrist W., Solca F., Stutz S., Giuffrè L., Carrel S., Girard J., Eberle A. N. Characterization of receptors for alpha-melanocyte-stimulating hormone on human melanoma cells. Cancer Res. 1989 Nov 15;49(22):6352–6358. [PubMed] [Google Scholar]
  11. Taylor I. W. A rapid single step staining technique for DNA analysis by flow microfluorimetry. J Histochem Cytochem. 1980 Sep;28(9):1021–1024. doi: 10.1177/28.9.6157714. [DOI] [PubMed] [Google Scholar]
  12. Wick M. M., Byers L., Frei E., 3rd L-dopa: selective toxicity for melanoma cells in vitro. Science. 1977 Jul 29;197(4302):468–469. doi: 10.1126/science.877570. [DOI] [PubMed] [Google Scholar]
  13. Wick M. M. Dopamine: a novel antitumor agent active against B-16 melanoma in vivo. J Invest Dermatol. 1978 Aug;71(2):163–164. doi: 10.1111/1523-1747.ep12546959.1. [DOI] [PubMed] [Google Scholar]
  14. Wick M. M. Levodopa and dopamine analogs as DNA polymerase inhibitors and antitumor agents in human melanoma. Cancer Res. 1980 May;40(5):1414–1418. [PubMed] [Google Scholar]
  15. Wick M. M., Rosowsky A., Ratliff J. Antitumor effects of L-glutamic acid dihydroxyanilides against experimental melanoma. J Invest Dermatol. 1980 Feb;74(2):112–114. doi: 10.1111/1523-1747.ep12520030. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES